文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

肾阻力指数对平均动脉压试验的反应性作为脓毒性休克早期平均动脉压目标的指导:一项生理学研究

Renal Resistive Index Responsiveness to a Mean Arterial Pressure Test As a Guide for Mean Arterial Pressure Target in the Early Phase of Septic Shock: A Physiological Study.
PubMed 文献 · Crit Care Med · 2026-08-03
一句话结论早期脓毒性休克中,MAP试验期间RRI下降未识别出能从更高MAP目标中改善肾功能获益的患者;RRI无下降者高MAP目标下尿量增多(探索性)。

这项前瞻性生理学与随机研究在早期脓毒性休克患者(去甲肾上腺素≥0.05 µg/kg/min启动9小时内,伴或不伴乳酸>2 mmol/L,排除慢性肾病或急需肾脏替代治疗)中,先进行标准化2小时MAP试验(65-70后80-85 mm Hg)并测RRI,RRI反应者定义为MAP试验期间RRI下降≥0.05。随后80例患者按MAP试验期间RRI反应分层,随机分配至低MAP目标(65-70)或高MAP目标(80-85 mm Hg)治疗5天。23例(29%)为RRI反应者;在RRI反应者中,更高MAP目标与肾脏结局改善无关;RRI无反应者高MAP目标下尿量更高,其他肾脏参数无显著差异,为探索性发现。

要点

  • 早期脓毒性休克MAP试验:2小时内MAP从65-70升至80-85 mm Hg,测RRI;RRI下降≥0.05定义为RRI反应者。
  • 80例随机,仅23例(29%)为RRI反应者;RRI反应者中高MAP目标(80-85 mm Hg)未改善利尿、KDIGO分期、RRT需求或血肌酐。
  • RRI无反应者高MAP目标下尿量更高,其他肾脏参数无显著差异,原文标注为探索性发现。
  • 研究为单中心生理学研究,样本量80例,RRI反应者仅23例,结论需前瞻性验证。

适用人群与场景

  • 早期脓毒性休克患者:去甲肾上腺素≥0.05 µg/kg/min基础量,启动9小时内,伴或不伴乳酸>2 mmol/L。
  • 排除慢性肾脏病或急需肾脏替代治疗的患者。
  • 场景:大学医院内科ICU。

诊断标准与关键阈值

  • RRI反应者定义:标准化2小时MAP试验(65-70后80-85 mm Hg)期间RRI下降≥0.05。
  • MAP目标分组:低目标65-70 mm Hg,高目标80-85 mm Hg,持续5天,按MAP试验期间RRI反应分层随机。

处置流程与药物剂量

  • 第一步:对早期脓毒性休克符合条件者行标准化2小时MAP试验,MAP从65-70升至80-85 mm Hg,各阶段测RRI。
  • 第二步:根据MAP试验期间RRI是否下降≥0.05判定RRI反应者。
  • 第三步:按RRI反应分层随机至低MAP目标(65-70 mm Hg)或高MAP目标(80-85 mm Hg)治疗5天。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:前瞻性生理学与随机研究,单中心,样本量80例。
  • 人群:早期脓毒性休克,去甲肾上腺素≥0.05 µg/kg/min启动9小时内,伴或不伴乳酸>2 mmol/L,排除慢性肾病或急需RRT。
  • 干预:标准化2小时MAP试验(65-70后80-85 mm Hg)测RRI,随后按RRI反应分层随机至低MAP目标(65-70)或高MAP目标(80-85 mm Hg)5天。
  • 主要结果:23例(29%)为RRI反应者;RRI反应者中高MAP目标与肾脏结局改善无关(利尿、KDIGO分期、RRT需求、血肌酐)。
  • 次要结果:RRI无反应者高MAP目标下尿量更高,其他肾脏参数无显著差异,为探索性发现。

证据类型、等级与局限

  • 证据类型:前瞻性生理学与随机研究,单中心,样本量80例。
  • 局限:单中心、样本量小(RRI反应者仅23例),RRI无反应者尿量发现为探索性,需前瞻性验证。

对床旁实践的改变

  • 在早期脓毒性休克中,MAP试验期间RRI下降≥0.05不能识别从更高MAP目标(80-85 mm Hg)改善肾功能获益的患者。
  • MAP试验期间RRI无下降可能帮助识别增加MAP与尿量增加相关的患者,但为探索性发现,不能作为决策阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Guidelines recommend targeting a mean arterial pressure (MAP) greater than or equal to 65 mm Hg in septic shock. Although experts advocate for individualized targets, no validated bedside tool exists. An increased renal resistive index (RRI) is associated with acute kidney injury, and increasing MAP can reduce RRI. This study investigated the physiologic impact of a higher MAP on renal function based on RRI evolution during a transient high MAP target test.

DESIGN: Prospective physiologic and randomized study.

SETTING: Medical ICU of a university hospital.

PATIENTS: Patients in the early phase of septic shock (norepinephrine ≥ 0.05 µg/kg/min base within 9 hr of initiation, with or without lactate > 2 mmol/L) without chronic kidney disease or immediate need for renal replacement therapy.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: All patients underwent a standardized 2-hour MAP test (65-70 followed by 80-85 mm Hg) with RRI measured at each period. RRI responders were defined by an RRI decrease greater than or equal to 0.05 during the MAP test. Following the MAP test, patients were randomized according to the "low" (65-70) or "high" (80-85 mm Hg) MAP target for 5 days, stratified by RRI response during the MAP test. Eighty patients were randomized; 23 (29%) were RRI responders. Among RRI responders, the higher MAP target was not associated with improved renal outcomes (i.e., diuresis, Kidney Disease: Improving Global Outcomes stage, need for renal replacement therapy, or serum creatinine). RRI nonresponders had higher urine output with a high MAP target, whereas no other renal parameter differed significantly; these findings should be considered exploratory.

CONCLUSIONS: In early septic shock, a decrease in RRI during a MAP test did not identify patients who would benefit from higher MAP targets to improve renal function. Conversely, the absence of an RRI decrease during the MAP test may help identify patients in whom increasing MAP is associated with increased urine output.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fage N, Bouizegarene M, Seegers V, et al. Renal Resistive Index Responsiveness to a Mean Arterial Pressure Test As a Guide for Mean Arterial Pressure Target in the Early Phase of Septic Shock: A Physiological Study. Crit Care Med. 2026. PMID: 42545101. doi:10.1097/CCM.0000000000007286

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。